argenx SE (argenx SE) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is argenx SE FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. argenx SE's Free Cash Flow for the three months ended in Dec. 2023 was $0 Mil. argenx SE's Revenue for the three months ended in Dec. 2023 was $407 Mil. Therefore, argenx SE's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, argenx SE's current FCF Yield % is -2.08%.

The historical rank and industry rank for argenx SE's FCF Margin % or its related term are showing as below:

ARGX' s FCF Margin % Range Over the Past 10 Years
Min: -978.59 Med: -145.38 Max: 133.69
Current: -37.85

During the past 13 years, the highest FCF Margin % of argenx SE was 133.69%. The lowest was -978.59%. And the median was -145.38%.

ARGX's FCF Margin % is ranked better than
64.31% of 1034 companies
in the Biotechnology industry
Industry Median: -148.935 vs ARGX: -37.85

argenx SE FCF Margin % Historical Data

The historical data trend for argenx SE's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE FCF Margin % Chart

argenx SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

133.69

-978.60

-146.45

-235.33

-37.85

argenx SE Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of argenx SE's FCF Margin %

For the Biotechnology subindustry, argenx SE's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

argenx SE's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's FCF Margin % distribution charts can be found below:

* The bar in red indicates where argenx SE's FCF Margin % falls into.

argenx SE FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

argenx SE's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-464.139	/	1226.316
	=	-37.85 %

argenx SE's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	406.837
	=	0.00 %

argenx SE FCF Margin % Related Terms

Thank you for viewing the detailed overview of argenx SE's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

argenx SE (argenx SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (NAS:ARGX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ARGX:Mexico ARGXb:UK 0QW0:UK 1AEA:Germany 1AE:Germany 1AE:Germany A1RG34:Brazil ARGX:Belgium ARGX:Austria

Address

Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB

Website

https://www.argenx.com

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.